Brian Lian
Director, President & CEO · 1 filing · Latest: Jul 28, 2026
Viking Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VKTX | Brian Lian | Director, President & CEO | Jul 29, 2026 | Sale | $33.32 | 148,517 | $4.9M | 2,572,441 | |
VKTX | BRIAN LIAN | — | Jul 29, 2026 | Proposed Sale | $33.32 | 148,517 | $4.9M | — | |
VKTX | BRIAN LIAN | — | Jan 5, 2026 | Proposed Sale | $32.96 | 233,409 | $7.7M | — | |
VKTX | BRIAN LIAN | — | Oct 28, 2025 | Proposed Sale | $35.01 | 38,989 | $1.4M | — | |
VKTX | BRIAN LIAN | — | Jul 3, 2025 | Proposed Sale | $27.80 | 26,889 | $747.6K | — | |
VKTX | BRIAN LIAN | — | Jan 6, 2025 | Proposed Sale | $42.75 | 194,490 | $8.3M | — | |
VKTX | Lian Brian | — | Sep 20, 2024 | Proposed Sale | $18.41 | 216,130 | $4.0M | — |